FDA NDC Directory · JSON-LD · Markdown

Buprenorphine and Naloxone

NDC 62175-458 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205022
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE (8 mg/1)
NALOXONE (2 mg/1)
Marketing started20160919
Package count1

External sources

Source: openFDA. Public-domain (CC0).